Femasys (FEMY) Consolidated Net Income (2020 - 2025)
Femasys (FEMY) posted Consolidated Net Income of -$4.6 million for Q2 2025, up 22.23% on a QoQ basis from -$5.9 million in Q1 2025, and up 2.11% year-over-year from -$4.5 million in Q2 2024.
Femasys (FEMY) Consolidated Net Income (2020 - 2025) Analysis & Trends
Femasys' Consolidated Net Income history runs 6 years deep, the most recent figure standing at -$4.6 million for Q2 2025.
- Quarterly Consolidated Net Income rose 2.11% year-over-year to -$4.6 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$4.6 million (up 78.28% YoY) and the FY2025 annual result came in at -$18.6 million, up 1.0% from the prior year.
- Consolidated Net Income was -$4.6 million for Q2 2025 at Femasys, up from -$5.9 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at -$1.1 million in Q2 2021 and bottomed at -$5.9 million in Q1 2025.
- A 5-year average of -$3.5 million and a median of -$3.1 million in 2022 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2021 — Consolidated Net Income increased 27.09% — and 2022, when it plunged 162.38%.
- Femasys' Consolidated Net Income stood at -$2.4 million in 2021, then slipped by 27.44% to -$3.0 million in 2022, then plunged by 46.34% to -$4.4 million in 2023, then fell by 16.17% to -$5.1 million in 2024, then rose by 10.5% to -$4.6 million in 2025.
- Business Quant data shows FEMY's Consolidated Net Income at -$4.6 million in Q2 2025, -$5.9 million in Q1 2025, and -$5.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -274.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -4.59 Mn |
| Mar 31, 2025 | -5.90 Mn |
| Dec 31, 2024 | -5.12 Mn |
| Sep 30, 2024 | -5.41 Mn |
| Jun 30, 2024 | -4.68 Mn |
| Mar 31, 2024 | -3.60 Mn |
| Dec 31, 2023 | -4.41 Mn |
| Sep 30, 2023 | -4.00 Mn |
| Jun 30, 2023 | -2.89 Mn |
| Mar 31, 2023 | -3.04 Mn |
| Dec 31, 2022 | -3.01 Mn |
| Sep 30, 2022 | -3.06 Mn |
| Jun 30, 2022 | -2.84 Mn |
| Mar 31, 2022 | -2.89 Mn |
| Dec 31, 2021 | -2.36 Mn |
| Sep 30, 2021 | -2.26 Mn |
| Jun 30, 2021 | -1.08 Mn |
| Mar 31, 2021 | -1.83 Mn |
| Dec 31, 2020 | -1.66 Mn |
| Sep 30, 2020 | -1.57 Mn |